1.Kochanek, K.D. et al. Deaths: Final data for 2009. Natl Vital Stat Rep. 2011, 60:1–116.
2.Mosca, L. et al., Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010, 3:120–7.
3.Roger, V.L. et al. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation. 2012, 125:e2–e220.
4.Patel, S.A. et al. Cardiovascular mortality associated with 5 leading risk factors: National and state preventable fractions estimated from survey data. Ann Intern Med. 2015, 163:245–53.
5.Lin, J.S., O’Connor, E., Evans, C.V. et al. Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: A systematic review for the US Preventive Services Task Force. Ann Intern Med. 2014, 161:568–78.
6.Taylor, F., Huffman, M.D., Macedo, A.F. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013 (1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
7.Writing Group, M. et al. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation. 2012, 125:e2–e220.
8.Helfand, M. and Carson, S. Screening for Lipid Disorders in Adults: Selective Update of 2001 U.S. Preventive Services Task Force Review. Evidence Synthesis No. 49. Rockville, MD: Agency for Healthcare Research and Quality.
9.Goff, D.C. Jr. et al., 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129:S49–73.
10.Draft Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. US Preventive Services Task Force.